New data showed that prior malignancy may influence survival outcomes in patients with metastatic colorectal cancer, ...

A young mother has revealed the symptoms that led to her stage 3 colorectal diagnosis. About 150,000 Americans are diagnosed ...

Every minute, 38 people are diagnosed with cancer, and 18 people die from it globally, according to the World Health ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Patients whose metastatic colorectal cancer has progressed following chemotherapy and who lack mutations in the RAS and BRAF ...

The 3-year local recurrence rate was 3.6% for transanal TME and 4.4% for laparoscopic TME. The 3-year overall survival was 92 ...

Pfizer's Braftovi combination showed significant survival benefits in a Phase 3 study for BRAF V600E-mutant metastatic ...